Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elodie Sollier"'
Autor:
Alex McMillan, Elodie Sollier, Vishnu C. Ramani, Sam W. Baker, Aryana M. Razmara, Grace N Kisirkoi, Margot B Bellon, Clementine A. Lemaire, Stefanie S. Jeffrey, Kerriann M. Casey
Publikováno v:
Clin Exp Metastasis
Patient-derived orthotopic xenograft (PDOX) models have been verified as a useful method for studying human cancers in mice. Previous studies on the extent of metastases in these models have been limited by the necessity of welfare euthanasia (primar
Autor:
Jose G. Vilches-Moure, Elodie Sollier, George W. Sledge, Rakhi Gupta, Clementine A. Lemaire, Vishnu C. Ramani, Aryana M. Razmara, Kyra Heirich, Kerriann M. Casey, Haiyu Zhang, Melanie Triboulet, Stefanie S. Jeffrey, Corinne Renier
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-16 (2019)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background Circulating tumor cells (CTCs) represent a temporal “snapshot” of a patient’s cancer and changes that occur during disease evolution. There is an extensive literature studying CTCs in breast cancer patients, and particularly in those
Autor:
Elodie Sollier Christen, Jonathan W. Goldman, Dino Di Carlo, James Che, David Elashoff, Rajan P. Kulkarni, Manjima Dhar, Jessica Wong, Tristan Grogan, Edward B. Garon, Melissa Matsumoto
Publikováno v:
Scientific reports, vol 8, iss 1
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Metastatic non-small cell lung cancer (NSCLC) is a highly fatal and immunogenic malignancy. Although the immune system is known to recognize these tumor cells, one mechanism by which NSCLC can evade the immune system is via overexpression of programm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d05faceeef49574b7bf08cd0b0cac59
https://escholarship.org/uc/item/9pm068bt
https://escholarship.org/uc/item/9pm068bt
Autor:
Kyra Heirich, Elodie Sollier-Christen, Todd A. Duncombe, Kevin A. Yamauchi, Julea Vlassakis, Stefanie S. Jeffrey, Amy E. Herr, Haiyan Huang, Elisabet Rosàs-Canyelles, James Che, Elly Sinkala, Corinne Renier
Publikováno v:
Nature Communications
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Circulating tumour cells (CTCs) are rare tumour cells found in the circulatory system of certain cancer patients. The clinical and functional significance of CTCs is still under investigation. Protein profiling of CTCs would complement the recent adv
Autor:
Susan McCloskey, James Che, Nicholas G. Nickols, Daniel R. Gossett, Westbrook M. Weaver, Derek E. Go, Elodie Sollier, Rajan P. Kulkarni, Jonathan H. Goldman, Matthew Rettig, Sean O'Byrne, Nicolas Kummer, Dino Di Carlo
Publikováno v:
Lab Chip. 14:63-77
A blood-based, low cost alternative to radiation intensive CT and PET imaging is critically needed for cancer prognosis and management of its treatment. "Liquid biopsies" of circulating tumor cells (CTCs) from a relatively non-invasive blood draw are
Autor:
Elodie Sollier-Christen, Melissa Matsumoto, Edward B. Garon, Kyra Heirich, Corinne Renier, Rosita Montoya, Derek E. Go, Manjima Dhar, Melanie Triboulet, Rajan P. Kulkarni, Rachel Conrad, Dino Di Carlo, Edward Pao, James Che, Nagesh Rao, Stefanie S. Jeffrey, Jianyu Rao, Jonathan H. Goldman
Publikováno v:
Scientific Reports
Circulating tumor cells (CTCs) have a great potential as indicators of metastatic disease that may help physicians improve cancer prognostication, treatment and patient outcomes. Heterogeneous marker expression as well as the complexity of current an
Autor:
Jonathan W. Goldman, Elodie Sollier, James Che, Jianyu Rao, Shruti Sheth, Edward B. Garon, Stefanie S. Jeffrey, Corinne Renier, Manjima Dhar, Rajan P. Kulkarni, George W. Sledge, Dino Di Carlo, Victor Yu, Mark D. Pegram, Kyra Heirich, Melissa Matsumoto
Publikováno v:
Oncotarget
Circulating tumor cells (CTCs) are emerging as rare but clinically significant non-invasive cellular biomarkers for cancer patient prognosis, treatment selection, and treatment monitoring. Current CTC isolation approaches, such as immunoaffinity, fil